69 filings
Page 4 of 4
8-K
6gckolqmn l8b8bln
26 Mar 20
Entry into a Material Definitive Agreement
4:30pm
8-K
cpxb6lo025ue9i
12 Mar 20
CNS Pharmaceuticals Announces Business Highlights and 2019 Fourth Quarter Financial Results
4:29pm
8-K
wopsgucixhenf5ic
10 Mar 20
Regulation FD Disclosure
4:05pm
8-K
9fxupeq
2 Mar 20
Regulation FD Disclosure
2:15pm
8-K
cytcnj9l2w4m
16 Jan 20
Entry into a Material Definitive Agreement
4:40pm
8-K
59q72l7x01a8h
16 Jan 20
Regulation FD Disclosure
10:18am
8-K
wtu2aghe1ry5 7g
13 Jan 20
Regulation FD Disclosure
10:24am
8-K
x8i3b9g9gsxa00wtx
22 Nov 19
CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option
8:00am
8-K
0g0ktxz9nlpr
14 Nov 19
CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock
12:00am